Skip to main content

Medtronic bone graft has limited benefit, may cause harm: reviews

Two long-awaited independent reviews of a controversial Medtronic Inc bone growth product show it works as well as traditional bone grafts taken from patients, but it may not be as safe.

The analyses, published on Monday in the Annals of Internal Medicine, suggest that Medtronic's Infuse product was associated with a small, increased risk of cancer, and that early published data on the trials underreported side effects and emphasized favorable results.

 

Writing in an editorial in the same journal, doctors said the Medtronic product should be reserved for certain, select patients, and that the costs and risks of the product should be clearly spelled out.

The reviews were prompted by questions raised by spine experts and U.S. lawmakers about the safety of the Infuse product, which contains a genetically-engineered protein used to promote bone growth known as recombinant human bone morphogenetic protein 2.

Infuse was once hailed as a major advance in spine surgery by offering a way to ease the pain of spinal fusion surgeries, in which bones in the neck or spine are fused together. Traditionally, a portion of bone known as a graft is harvested from other parts of the body to encourage bone healing. Infuse was developed to promote bone healing without the need for painful bone harvesting.

But in 2011, Infuse became the subject of investigations by the U.S. Senate and the Department of Justice over omissions of safety problems from its clinical trial data and over off-label use.

The product also drew intense public scrutiny after the influential Spine Journal ran an entire issue criticizing the product in June 2011, charging that surgeons, who were paid tens of millions of dollars by Medtronic, failed to report serious complications, such as male sterility, increased risk of cancer, infections, bone dissolution and worsened back and leg pain.

To address these questions, Medtronic in 2011 agreed to two independent reviews of its trial data. As part of the Yale University Open Data Access project - spearheaded by Dr. Harlan Krumholz - teams of researchers at Oregon Health & Science University in Portland and Britain's University of York, were selected to conduct the reviews.

The Oregon team found that in spinal fusion, the Medtronic product worked no better than bone harvested from a patient's own body.

In trials, Infuse was compared to iliac crest bone graft, which involves taking bone from the rim of the pelvic bone, which can lead to complications such as pain or infection.

The Oregon review also found that Infuse was associated with an increased risk of cancer after two years, although the overall risk was low and did not involve a particular type of malignancy. They also found that published trial data emphasized the positive, while underreporting side effects.

The University of York researchers found that after two years, Infuse offered no clinically important pain reduction and was associated with a possible increased risk of cancer, although again, the overall risk was low.

The findings suggest that Infuse should be used primarily as an alternative for patients who otherwise would require more than one incision to harvest their own bone for grafting at the surgery site, according to an editorial by Dr Daniel Resnick of the University of Wisconsin and Dr Kevin Bozic of the University of California, San Francisco.

They said patients should be counseled on the relative benefits and harms, as well as the costs of each graft option.

Medtronic had a somewhat more positive take on the conclusions of the reviews.

"The findings reinforced what we know about the product in the sense that the studies concluded equivalence, and in some cases superiority, to iliac crest bone harvesting," said Chris O'Connell, president of Medtronic's Restorative Therapies Group. "It's really up to the physician to interpret the data."

_0">

He said Medtronic views its cooperation with the Infuse reviews as part of a bigger industry trend toward open access to medical trial data.

_1">

The company said it has funded an analysis of real-world usage of Infuse to gauge its association with cancer risk and expects those results to be presented at a medical meeting in the fall.

_2">

The U.S. Food and Drug Administration approved Infuse in 2002 to stimulate spinal bone growth in patients with a degenerative disease affecting the lower spine.

_3">

In March 2012, Medtronic agreed to pay $85 million to settle a shareholder lawsuit accusing it of failing to reveal that as much as 85.2 percent of Infuse sales depended on so-called "off-label" uses, where doctors prescribe the product for applications not approved by the FDA.

_4">

The product had sales of $528 million in fiscal 2013, far below the $800 million the company reported in fiscal 2011.

_5">

(Reporting By Deena Beasley; Editing by Julie Steenhuysen, Bernard Orr)

_6">

Popular posts from this blog

Study Abroad USA, College of Charleston, Popular Courses, Alumni

Thinking for Study Abroad USA. School of Charleston, the wonderful grounds is situated in the actual middle of a verifiable city - Charleston. Get snatched up by the wonderful and customary engineering, beautiful pathways, or look at the advanced steel and glass building which houses the School of Business. The grounds additionally gives students simple admittance to a few major tech organizations like Amazon's CreateSpace, Google, TwitPic, and so on. The school offers students nearby as well as off-grounds convenience going from completely outfitted home lobbies to memorable homes. It is prepared to offer different types of assistance and facilities like clubs, associations, sporting exercises, support administrations, etc. To put it plainly, the school grounds is rising with energy and there will never be a dull second for students at the College of Charleston. Concentrate on Abroad USA is improving and remunerating for your future. The energetic grounds likewise houses various

Best MBA Online Colleges in the USA

“Opportunities never open, instead we create them for us”. Beginning with this amazing saying, let’s unbox today’s knowledge. Love Business and marketing? Want to make a high-paid career in business administration? Well, if yes, then mate, we have got you something amazing to do!   We all imagine an effortless future with a cozy house and a laptop. Well, well! You can make this happen. Today, with this guide, we will be exploring some of the top-notch online MBA universities and institutes in the USA. Let’s get started! Why learn Online MBA from the USA? Access to More Options This online era has given a second chance to children who want to reflect on their careers while managing their hectic schedules. In this, the internet has played a very crucial in rejuvenating schools, institutes, and colleges to give the best education to students across the globe. Graduating with Less Debt Regular classes from high reputed institutes often charge heavy tuition fees. However onl

Sickening moment maskless 'Karen' COUGHS in the face of grocery store customer, then claims she doesn't have to wear a mask because she 'isn't sick'

A woman was captured on camera following a customer through a supermarket as she coughs on her after claiming she does not need a mask because she is not sick.  Video of the incident, which has garnered hundreds of thousands of views on Twitter alone, allegedly took place in a Su per Saver in Lincoln, Nebraska according to Twitter user @davenewworld_2. In it, an unidentified woman was captured dramatically coughing as she smiles saying 'Excuse me! I'm coming through' in the direction of the customer recording her. Scroll down for video An unidentified woman was captured dramatically coughing as she smiles saying 'Excuse me! I'm coming through' in the direction of a woman recording her A woman was captured on camera following a customer as she coughs on her in a supermarket without a mask on claiming she does not need one because she is not sick @chaiteabugz #karen #covid #karens #karensgonewild #karensalert #masks we were just wearing a mask at the store. ¿ o